Metlife Inc [MET] stock prices are up 0.66% to $82.25 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MET shares have gain 1.23% over the last week, with a monthly amount drifted -5.01%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Metlife Inc [NYSE: MET] stock has seen the most recent analyst activity on October 09, 2024, when TD Cowen initiated its Buy rating and assigned the stock a price target of $97. Previously, Barclays started tracking the stock with Overweight rating on September 05, 2024, and set its price target to $91. On January 08, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $80 on the stock. Deutsche Bank initiated its recommendation with a Hold and recommended $71 as its price target on October 05, 2023. Jefferies upgraded its rating to Buy for this stock on September 14, 2023, and upped its price target to $72. In a note dated January 09, 2023, Goldman downgraded an Neutral rating on this stock and revised its target price from $80 to $78.
The stock price of Metlife Inc [MET] has been fluctuating between $64.61 and $89.05 over the past year. Currently, Wall Street analysts expect the stock to reach $90.5 within the next 12 months. Metlife Inc [NYSE: MET] shares were valued at $82.25 at the most recent close of the market. An investor can expect a potential return of 10.03% based on the average MET price forecast.
Analyzing the MET fundamentals
The Metlife Inc [NYSE:MET] reported sales of 71.35B for trailing twelve months, representing a surge of 16.22%. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at 0.07%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.13 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.61.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 81.65 points at the first support level, and at 81.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.64, and for the 2nd resistance point, it is at 83.03.
Ratios To Look Out For
It’s worth pointing out that Metlife Inc [NYSE:MET]’s Current Ratio is 4.17. Considering the valuation of this stock, the price to sales ratio is 0.80, the price to book ratio is 1.85 and price to earnings (TTM) ratio is 16.59.
Transactions by insiders
Recent insider trading involved Metlife 401(k) Plan Large cap, Affiliate discretionary manage, that happened on Dec 20 ’24 when 236.0 shares were purchased. Affiliate, Separate Account 149 completed a deal on Dec 20 ’24 to buy 15.0 shares. Meanwhile, Affiliate Separate Account SPI bought 893.0 shares on Dec 20 ’24.
